Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
19 studies found for:    "Yellow fever"
Show Display Options
Rank Status Study
1 Recruiting Human Immune Responses to The Yellow Fever Virus Vaccine
Condition: Yellow Fever
Intervention: Biological: Yellow fever vaccine
2 Completed Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers
Conditions: Dengue;   Dengue Hemorrhagic Fever;   Yellow Fever
Interventions: Biological: Live, attenuated dengue serotype 1, 2, 3, and 4 virus;   Biological: Yellow fever vaccine;   Biological: Measles, mumps, and rubella vaccine;   Biological: Pneumococcal Conjugated Vaccine;   Biological: Hepatitis A Pediatric Vaccine;   Biological: Diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae vaccine;   Biological: Yellow Fever Vaccine;   Biological: Placebo (NaCl)
3 Unknown  Trial of Yellow Fever Inactivated Vaccine
Condition: Yellow Fever
Interventions: Biological: XRX-001 Inactivated yellow fever vaccine;   Biological: Placebo
4 Recruiting Turnover of Antigen Specific Lymphocytes After Immunization With the Yellow Fever Vaccine
Condition: Yellow Fever
Interventions: Biological: Yellow fever vaccine;   Biological: Yellow fever vaccine and D20 water
5 Completed Characterization of T Cell Responses Following Yellow Fever Virus Vaccination in Healthy Adults
Condition: Yellow Fever
6 Completed Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever;   Yellow Fever
Interventions: Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus;   Biological: Yellow Fever
7 Completed
Has Results
Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)
Conditions: Japanese Encephalitis;   Yellow Fever
Interventions: Biological: Live attenuated Japanese encephalitis virus; Yellow fever virus;   Biological: Yellow fever virus; Live attenuated Japanese encephalitis virus;   Biological: Live attenuated Japanese encephalitis virus; Yellow fever virus
8 Recruiting Immune Responses to Yellow Fever Vaccine
Condition: Prior Receipt of Yellow Fever Vaccine
9 Active, not recruiting The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.
Conditions: HIV Infection;   Yellow Fever
Intervention: Biological: Yellow fever vaccination (STAMARIL)
10 Recruiting The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans
Conditions: Yellow Fever;   Encephalitis, Japanese
Interventions: Biological: Japanese Encephalitis vaccine;   Biological: Yellow Fever vaccine
11 Completed
Has Results
A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults
Conditions: Meningococcal Disease;   Meningococcal Meningitis;   Typhoid;   Yellow Fever;   Rabies;   Japanese Encephalitis
Interventions: Biological: Typhoid Vi Polysaccharide Vaccine;   Biological: Yellow Fever Vaccine;   Biological: Japanese Encephalitis Vaccine;   Biological: Rabies Vaccine;   Biological: MenACWY-CRM  Vaccine
12 Completed Yellow Fever Virus Vaccine and Immune Globulin Study
Condition: Viremia
Interventions: Biological: YF-VAX® plus saline;   Biological: 17D YF Vaccine plus Ig,
13 Completed
Has Results
Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Biological: Live Yellow Fever Vaccine (YFV-17D);   Drug: YFV-17D Placebo
14 Completed The Effect of Extended Yellow Fever Vaccine Information on Symptom Reports Following Vaccination
Condition: Vaccination
Intervention: Behavioral: Extended information on side effects
15 Completed Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines
Condition: Healthy
Interventions: Biological: Varicella-zoster virus;   Biological: Yellow Fever Vaccine;   Biological: Placebo
16 Completed Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Virus
Intervention: Biological: Chimeric dengue serotype (1, 2, 3, 4)
17 Completed Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years
Conditions: Dengue Virus;   Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Diseases
Interventions: Biological: Chimeric dengue serotype 1, 2, 3, and 4;   Biological: Pneumococcal polysaccharide vaccine
18 Active, not recruiting IPV Clinical Trial - The Gambia
Condition: Poliomyelitis
Interventions: Drug: IPV IM Needle;   Drug: IPV ID Needle;   Drug: IPV IM Device;   Drug: IPV ID Device
19 Completed
Has Results
Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen
Condition: Malaria Vaccines
Interventions: Biological: GSK 257049;   Biological: Tritanrix™ HepB/Hib;   Biological: Rouvax™;   Biological: Stamaril™;   Biological: Polio Sabin™

Indicates status has not been verified in more than two years